Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

670 IndexDepressionin adolescents, 566–567alcohol abuse and, 79, 99, 443–444cocaine abuse and, 194in cocaine withdrawal, 202comorbid substance use disorder, 273,277in elderly, 404–405gender differences, 253genetic risk, 442immune function and, 417–418impulse control disorders and, 306pharmacotherapy with duallydiagnosed patients, 286, 606Desensitization therapy for pathologicalgambling, 313Desipramine, 289, 575Detoxificationalcohol, 591–593clinical evolution, 30elderly patients, 401family involvement, 540–541opioid, 597–598pharmacotherapy, 639Dextromethorphan, 65Diagnostic and Statistical Manual of MentalDisorders, 356, 561alcohol abuse disorders, 76nicotine dependence criteria, 110–111polysubstance abuse diagnosis, 245–247Diagnostic Interview Schedule, 48Dialectical behavior therapy, 495–496applications, 615, 616assumptions and agreements, 620–622case management in, 634conceptual basis, 617–618, 634–635conceptualization of borderlinepersonality disorder in, 618–620consultation team, 633effectiveness, 617future prospects, 634–635individual psychotherapy in, 627–632modes of treatment, 624pharmacotherapy in, 633–634rationale, 616skills training groups in, 624–627telephone consultation, 632therapeutic relationship, 623–624,630–631treatment targets, 622–623Diazepam, 225, 228, 401Dietary uses of drugs, 22Diphenylhydrantoin, 65Disability, addiction as, 360Disinhibition, neurobehavioral, 44–45,255, 262Disruptive Behavior Rating Scale, 54–55Disulfiram, 24, 402, 405, 534adolescent treatment, 575behavioral interventions with, 645for cocaine abuse treatment, 603contraindications, 593effectiveness, 593, 645side effects, 593therapeutic action, 593, 645Divorce and child custody issues, 359Domestic violence, 357Dopaminergic systemalcohol use and, 85cocaine action, 189, 190, 191comorbidity considerations inpharmacotherapy, 606in drug reinforcement, 3, 5, 6in impulse control disorders, 307methamphetamine effects, 207–208neurobiology of addiction, 9–10neurobiology of tolerance, 7in schizophrenia, 81Drug and Alcohol Testing IndustryAssociation, 66Drug-free workplace, 68, 69–71Drug-Free Workplace Act, 69, 341Drug interactions, 397–398in opioid-substitute maintenancetherapy, 602–603Drug Use Screening Inventory, 45, 47EEating disorderscomorbid substance abuse and, 81co-occurring kleptomania, 314